Lysbeth Bakker

Lysbeth Bakker, MSc is an active researcher specializing in regulatory decision-making within medicine, with particular expertise in biomarker applications and real-world evidence frameworks. Her work directly engages with the European Medicines Agency's regulatory processes and contributes to UN Sustainable Development Goals related to health and well-being.

Her research interests center on Regulatory Decision Making, Biomarkers, and Real-World Evidence with specific focus on neurodegenerative diseases, precision medicine implementation, and patient registry utilization. The fingerprint analysis of her work reveals strong connections to Medicine and Dentistry (100%), Decision Making (87%), Regulatory Decision Making (85%), and Biological Markers (85%).

Analysis of her publication trends shows increasing focus on structured frameworks for real-world data utilization (2023-2025), with significant contributions to understanding how biomarkers inform regulatory decisions for neurodegenerative conditions and precision medicine applications. Her collaborative work demonstrates strong engagement with European regulatory bodies and methodology development for evidence generation.

• European Medicines Agency regulatory processes
• Real-world evidence integration frameworks
• Biomarker validation for drug approval
• Patient registry optimization

Bakker maintains active research collaborations across European institutions as evidenced by her co-authorship network, with frequent partnerships on regulatory science projects. Her work appears in high-impact pharmacology and clinical research journals with substantial readership and media attention, including coverage by news outlets and academic social media platforms.